Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
HypertriglyceridemiaGlucose Intolerance
Interventions
OTHER

20% Intralipid

Participants will receive a 5 h primed (375 mL/m2)-continuous (25 mL h-1 m-2) i.v. infusion of 20% fat emulsion (Intralipid 20%), together with a 5 h primed (28 µmol/kg)-continuous (0.28 µmol min-1 kg-1) infusion of 6,6-\[2H2\]glucose. After 2 h, participants will consume within 5 min an oral glucose drink consisting of 147 mL of 50% dextrose solution (wt/vol) enriched with 1.5 g of \[U-13C\] glucose.

OTHER

Normal Saline

Participants will receive a 5 h primed (375 mL/m2)-continuous (25 mL h-1 m-2) i.v. infusion of normal saline (Sodium Chloride 0.9%), together with a 5 h primed (28 µmol/kg)-continuous (0.28 µmol min-1 kg-1) infusion of 6,6-\[2H2\]glucose. After 2 h, participants will consume within 5 min an oral glucose drink consisting of 147 mL of 50% dextrose solution (wt/vol) enriched with 1.5 g of \[U-13C\] glucose.

Trial Locations (1)

56127

Azienda Ospedaliero-Universitaria Pisana, Pisa

All Listed Sponsors
lead

Azienda Ospedaliero, Universitaria Pisana

OTHER

NCT05181514 - Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity | Biotech Hunter | Biotech Hunter